Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

Photodegradation as a mechanism for controlled drug delivery

Photodegradable Polyurethane Self-Assembled Nanoparticles for Photocontrollable Release

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Light responsive hydrogels for controlled drug delivery

Transparent Low Molecular Weight Poly(Ethylene Glycol) Diacrylate-Based Hydrogels as Film Media for Photoswitchable Drugs

Controlled release of photoswitch drugs by degradable polymer microspheres

Photosensitive Cross‐linked Block Copolymers with Controllable Release

Photo-cross-linked hydrogels from thermoresponsive PEGMEMA-PPGMA-EGDMA copolymers containing multiple methacrylate groups: mechanical property, swelling, protein release, and cytotoxicity.

Photo-controllable molecular hydrogels for drug delivery.

NIR Light‐Triggered Quantitative Pulsed Drug Release

Light-induced release of molecules from polymers

Erosion Induced Controllable Release of Gliclazide Encapsulated Inside Degradable Polymeric Particles

Photochemical mechanisms of light-triggered release from nanocarriers

Synthesis of Light-Induced Expandable Photoresponsive Polymeric Nanoparticles for Triggered Release

Light-Controlled Nanocarriers for Drug Release

Photomechanically Controlled Encapsulation and Release from pH-Responsive and Photoresponsive Microcapsules

Photo-induced drug release at interfaces with arylazopyrazoles

Visible Light Degradable Micelles for Intraocular Corticosteroid Delivery

Photo-Responsive Polymeric Nanocarriers For On-Demand Drug Delivery

A Red-Light-Responsive DASA–Polymer with High Water Stability for Controlled Release

Photopolymerized hydrogel materials for drug delivery applications